CX Institutional’s Pediatrix Medical MD Stock Holding History

CX Institutional’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-347	Closed	-$7K	–	1623
2025 Q4	$7K	Buy	+347	New	+$7.11K	﹤0.01%	1233

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CX Institutional's MD Position: Q1 2026 in Review

CX Institutional sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 347 shares — an estimated $7K sold.

CX Institutional first reported a position in MD in Q4 2025 and held it in 1 quarter. The position peaked at $7K in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

CX Institutional reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
CX Institutional sold 347 Pediatrix Medical shares in Q1 2026, an estimated $7K.
CX Institutional first reported a position in Pediatrix Medical in Q4 2025 and held it in 1 quarter.
CX Institutional's Pediatrix Medical position peaked at $7K in Q4 2025.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on CX Institutional's 13F filing for Q1 2026, filed 6 Apr 2026.